Clinical trial
PREventing Progression of Adipose Tissue Redistribution
NCT00389194 · International Antiviral Therapy Evaluation Center, Other · Completed
Key facts
| NCT number | NCT00389194 |
|---|---|
| Title | PREventing Progression of Adipose Tissue Redistribution |
| Official title | A Randomized, Controlled, Open-Label, 48-Week Study of Continuing Successfully Suppressive Treatment in HIV-1 Infected Adults With First-Line Twice-Daily Zidovudine and Lamivudine-Based Regimens Versus Pro-actively Replacing of Zidovudine and Lamivudine by Once-Daily Emtricitabine and Tenofovir… |
| Lead sponsor | International Antiviral Therapy Evaluation Center, Other |
| Collaborators | Gilead Sciences Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | HIV Infections |
| Intervention type | Drug |
| Interventions | continuing AZT+3TC or switching AZT+3TC to TDF+ FTC |
| Enrollment | 120 |
| Start date | Apr 1, 2006 |
| Completion | Oct 1, 2008 |
| First posted | Oct 18, 2006 |
| Last update posted | Jun 11, 2010 |
| Countries | Netherlands |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: